Singapore, Dec. 26 -- French biopharmaceutical firm Sanofi has entered into an agreement to acquire US-based Dynavax Technologies Corporation, a publicly traded vaccines company with a marketed adult ... Read More
Singapore, Dec. 26 -- The World Health Organization (WHO) has formally recognised the regulatory authorities for medical products of Australia and Indonesia as WHO Listed Authorities (WLAs), an achiev... Read More
Singapore, Dec. 26 -- In alignment with the national framework for the advancement of proton therapy, facilitated by the National Cancer Center,HKSH Medical Group (HKSH) and Cancer Hospital Chinese Ac... Read More
Singapore, Dec. 23 -- AeviceMD Monitoring System, a non-invasive wearable respiratory monitoring solution developed by Singapore-based Aevice Health, has been included in the Australian Register of Th... Read More
Singapore, Dec. 23 -- Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture (Ohito) to Shonan Health Innovation Park (Shonan iPark) in Jan... Read More
Singapore, Dec. 23 -- The International Vaccine Institute (IVI) and the Korea Disease Control and Prevention Agency (KDCA), together with four partner institutions, have signed a Memorandum of Underst... Read More
Singapore, Dec. 22 -- Japan-based Chitose Laboratory Corp. and Fujifilm Biosciences Inc. have announced a new strategic alliance that leverages the strengths of both companies in advancing biopharmace... Read More
Singapore, Dec. 22 -- South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has announced that its wholly owned US subsidiary, Samsung Biologics Am... Read More
Singapore, Dec. 22 -- Researchers in Australia have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially reduce malaria transmission... Read More
Singapore, Dec. 22 -- China-based Jacobio Pharma has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73.AstraZeneca will receive exclusive development and commercia... Read More